Nutanix Survey: 99% of Healthcare Organizations Now Use GenAI, Face Data Security, Integration Challenges

Nutanix Inc. (NASDAQ:NTNX) is one of the best tech stocks to buy under $100. On July 1, Nutanix announced the findings of its seventh annual global Healthcare Enterprise Cloud Index/ECI survey and research report. This report measured cloud adoption progress in the healthcare industry and revealed that an astonishing 99% of healthcare organizations surveyed are currently using GenAI applications or workloads.

These applications range from AI-powered chatbots to code co-pilots and clinical development automation. Despite rapid adoption, the majority of these organizations report that their current data security and governance measures are insufficient to fully support GenAI at scale.

Healthcare leaders face several hurdles in integrating GenAI. The primary concern, which was flagged by 79% of respondents, is the difficulty in integrating GenAI with existing IT infrastructure. This is closely followed by the persistence of healthcare data silos (65%) and ongoing development challenges with cloud-native applications and containers (59%).

Nutanix Inc. (NASDAQ:NTNX) provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

While we acknowledge the potential of NTNX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.